Holen Sie sich die Stockscreener-App
2.93
7.28%
-0.23
Handel nachbörslich:
2.94
0.010
+0.34%
Schlusskurs vom Vortag:
$3.16
Offen:
$3
24-Stunden-Volumen:
6,663
Relative Volume:
0.47
Marktkapitalisierung:
$1.65M
Einnahmen:
$17.86M
Nettoeinkommen (Verlust:
$-3.67M
KGV:
-0.2892
EPS:
-10.1315
Netto-Cashflow:
$-5.40M
1W Leistung:
+11.83%
1M Leistung:
+7.72%
6M Leistung:
-38.19%
1J Leistung:
-15.07%
1-Tages-Spanne:
$2.8601
$3.10
1-Wochen-Bereich:
$2.56
$3.16
52-Wochen-Spanne:
$2.00
$11.00
Universe Pharmaceuticals Inc Stock (UPC) Company Profile
Compare UPC vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UPC
Universe Pharmaceuticals Inc
|
2.93 | 1.78M | 17.86M | -3.67M | -5.40M | -10.13 |
TAK
Takeda Pharmaceutical Co Adr
|
18.22 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
ZTS
Zoetis Inc
|
118.26 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
HLN
Haleon Plc Adr
|
9.92 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.82 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
UTHR
United Therapeutics Corp
|
559.65 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Universe Pharmaceuticals Inc Aktie (UPC) Neueste Nachrichten
CDT PE Ratio & Valuation, Is CDT Overvalued - Intellectia AI
PRFX PE Ratio & Valuation, Is PRFX Overvalued - Intellectia AI
Stock List: Research Stocks from Around the World - gurufocus.com
Universe Pharmaceuticals Inc (UPC) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
UPC Should I Buy - Intellectia AI
CNSP PE Ratio & Valuation, Is CNSP Overvalued - Intellectia AI
Retail Surge: How Universe Pharmaceuticals INC stock compares to market leaders2026 Movers & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
UPC SEC FilingsUniverse Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Sell Signal: Should you avoid WTBA stock right now2026 Bull vs Bear & Real-Time Price Movement Reports - baoquankhu1.vn
Iterum Therapeutics PLC (ITRM) Stock Price, Quote, News & History - Benzinga
Chipmakers Recap: Is Addex Therapeutics Ltd Depositary Receipt stock a falling knife or bargain buyQuarterly Trade Review & Consistent Return Investment Signals - baoquankhu1.vn
Investor Mood: Is VLGEA benefiting from interest rate changes2026 Rallies & Reliable Trade Execution Plans - baoquankhu1.vn
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Portfolio Shifts: Should I invest in Universe Pharmaceuticals INC before earnings2026 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Universe Pharmaceuticals (NASDAQ: UPC) director Zheng Ding files Form 3 - Stock Titan
Universe Pharmaceuticals (UPC) CEO lists 3,467 Class B shares - Stock Titan
Universe Pharmaceuticals (NASDAQ: UPC) COO Liu Baochang files initial insider Form 3 - Stock Titan
Universe Pharmaceuticals (UPC) director Pang Jiawen files initial Form 3 - Stock Titan
Universe Pharmaceuticals (UPC) CFO Yang Lin files initial insider Form 3 - Stock Titan
Universe Pharmaceuticals (UPC) director Yu Yongping files initial Form 3 - Stock Titan
Aug Levels: Should I invest in Universe Pharmaceuticals INC before earningsBuy Signal & Fast Entry and Exit Trade Plans - baoquankhu1.vn
Ncc Group (OTCMKTS:NCCGF) & Aurora Innovation (NASDAQ:AUR) Financial Review - Defense World
Aug Patterns: Whats the fair value of HWKN stockJuly 2025 Summary & Low Risk Growth Stock Ideas - baoquankhu1.vn
Will DigitalBridge Group Inc. (6CL) stock remain on Wall Street radarTrade Risk Summary & Weekly Market Pulse Alerts - Naître et grandir
History Review: How is SFST managing supply chain issues2025 Market Trends & Weekly High Conviction Ideas - baoquankhu1.vn
Weekly Earnings: Can SEAT deliver consistent dividendsM&A Rumor & Weekly High Return Stock Forecasts - baoquankhu1.vn
Here's Why Shuttle Pharma is the Most Undervalued Biotech Stock in Our Coverage Universe - stocktwits.com
Can Lulus Fashion Lounge Holdings Inc lead its sector in growthStop Loss & Reliable Trade Execution Plans - baoquankhu1.vn
PRFX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
EON Resources (NYSEAMERICAN:EONR) Trading Up 28.5% – Here’s Why - Defense World
GCTK Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
SXTC PE Ratio & Valuation, Is SXTC Overvalued - Intellectia AI
UK Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
UPC Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Universe Pharmaceuticals (NASDAQ:UPC) Shares Down 1.2% – Here’s Why - Defense World
S&E In Brief: Commercial Updates From The SMID Cap Universe - Citeline News & Insights
SHPH Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Recap Report: Why ChargePoint Holdings Inc. stock is rated strong buyTrade Performance Summary & Technical Entry and Exit Tips - baoquankhu1.vn
Mattel Unveils Expansive Masters of the Universe Publishing Program Ahead of the Film’s Global Theatrical Release - Yahoo Finance
Aug Swings: What is Genfit SA Depositary Receipts revenue forecastCEO Change & Comprehensive Market Scan Insights - baoquankhu1.vn
AZTR PE Ratio & Valuation, Is AZTR Overvalued - Intellectia AI
Will COOT stock continue dividend increasesJuly 2025 Gainers & Reliable Entry Point Trade Alerts - mfd.ru
Is Universe Pharmaceuticals INC benefiting from interest rate changesExit Point & Free Long-Term Investment Growth Plans - mfd.ru
UPC Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Universe Pharmaceuticals INC Announces Effective Date of Dual-Class Share Structure - marketscreener.com
UPC PE Ratio & Valuation, Is UPC Overvalued - Intellectia AI
Bank Watch: Can SHQAU keep up with sector leaders2025 Winners & Losers & Stepwise Entry/Exit Trade Alerts - baoquankhu1.vn
Xenetic Biosciences appoints James Parslow as interim CEO - Intellectia AI
Universe Pharmaceuticals Sets February 13 Effective Date for Dual-Class Share Structure - TipRanks
AMC Networks Inc. Reports Fourth Quarter and Full Year 2025 Results - The Manila Times
Finanzdaten der Universe Pharmaceuticals Inc-Aktie (UPC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.35%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):